Cognex (NASDAQ:CGNX) Rating Lowered to “Hold” at Wall Street Zen

Cognex (NASDAQ:CGNXGet Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

Several other analysts also recently weighed in on CGNX. Cantor Fitzgerald lifted their target price on shares of Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a report on Friday. JPMorgan Chase & Co. upgraded Cognex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $65.00 to $75.00 in a research note on Tuesday, May 26th. Robert W. Baird set a $72.00 price target on Cognex in a research report on Friday, May 8th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $91.00 price objective on shares of Cognex in a research note on Friday. Finally, Citigroup reiterated a “neutral” rating and issued a $74.00 price objective (up from $72.00) on shares of Cognex in a report on Friday. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $75.85.

View Our Latest Stock Analysis on Cognex

Cognex Stock Performance

Shares of CGNX opened at $66.89 on Friday. The company’s 50-day moving average price is $65.01 and its 200 day moving average price is $57.27. Cognex has a 12-month low of $34.60 and a 12-month high of $72.88. The firm has a market cap of $11.25 billion, a P/E ratio of 64.94 and a beta of 1.49.

Cognex (NASDAQ:CGNXGet Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. The business had revenue of $291.26 million during the quarter, compared to analysts’ expectations of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The business’s revenue for the quarter was up 16.9% on a year-over-year basis. During the same period last year, the business earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities research analysts forecast that Cognex will post 1.65 earnings per share for the current year.

Insider Buying and Selling at Cognex

In other news, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the sale, the vice president owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total value of $2,727,296.00. Following the completion of the sale, the vice president owned 5,258 shares in the company, valued at approximately $344,714.48. The trade was a 88.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Cognex

Several large investors have recently bought and sold shares of CGNX. BlackRock Inc. acquired a new stake in Cognex in the 2nd quarter valued at about $1,158,123,000. Northwestern Mutual Wealth Management Co. grew its position in shares of Cognex by 173,138.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock worth $376,979,000 after buying an additional 10,471,400 shares in the last quarter. Norges Bank purchased a new stake in shares of Cognex during the fourth quarter worth approximately $73,103,000. Alyeska Investment Group L.P. purchased a new stake in shares of Cognex during the fourth quarter worth approximately $68,388,000. Finally, Bank of New York Mellon Corp acquired a new stake in Cognex in the second quarter valued at approximately $129,348,000. Hedge funds and other institutional investors own 88.12% of the company’s stock.

More Cognex News

Here are the key news stories impacting Cognex this week:

  • Positive Sentiment: Strong earnings and raised guidance: Cognex reported adjusted EPS of $0.45, exceeding the $0.42 consensus and rising from $0.25 a year ago. Revenue reached a record $291 million, up 16.9% year over year, while margin improvement, favorable product mix and cost controls boosted profitability. The company raised full-year 2026 adjusted EPS guidance to $1.64–$1.68, versus the $1.48 consensus, and projected third-quarter EPS of $0.50–$0.54. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
  • Positive Sentiment: Growth opportunities are broadening: Management highlighted AI-enabled machine vision, data-center expansion and increasing business with existing customers as growth drivers. Investors are also encouraged by strength across most major end markets and improving margins. Cognex Q2 Earnings Call Centers on AI and Data Center Growth
  • Positive Sentiment: Analyst targets moved higher: Cantor Fitzgerald raised its target to $84 and assigned an overweight rating, Needham lifted its target to $80 with a buy rating, and Truist increased its target to $78 while maintaining a hold rating. The revisions signal greater confidence in Cognex’s earnings trajectory. Analyst price-target updates
  • Neutral Sentiment: Revenue modestly missed estimates: Quarterly revenue of approximately $291 million was slightly below the $292.1 million consensus, but the shortfall was offset by stronger margins and earnings. Cognex misses Q2 revenue estimates
  • Negative Sentiment: Insider selling may temper enthusiasm: Recent disclosures indicate company insiders made 16 sales and no purchases over the past six months. This does not necessarily indicate deteriorating fundamentals, but it can add a valuation-related overhang.

About Cognex

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Featured Articles

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.